Canature Health(SZ:300272) Zheng Quan Zhi Xing·2025-09-01 04:13Core Viewpoint - The company has announced the early redemption of its convertible bonds ("开能转债") due to the stock price exceeding the specified threshold, urging bondholders to convert their bonds before the deadline to avoid potential losses [1][2][6]. Group 1: Convertible Bond Details - The company issued 2.5 million convertible bonds with a total value of 250 million yuan, each with a face value of 100 yuan [2][5]. - The initial conversion price was set at 5.67 yuan per share, which has been adjusted multiple times due to dividend distributions, with the latest adjustment bringing it to 5.36 yuan per share [3][4][6]. - The bonds have a conditional redemption clause that allows the company to redeem them if the stock price remains above 130% of the conversion price for a specified period [5][6]. Group 2: Redemption Process - The redemption price for the bonds is confirmed at 100.118 yuan per bond, which includes accrued interest calculated based on the bond's face value and interest rate [6][7]. - The redemption will occur on September 2, 2025, with bondholders needing to ensure their holdings are not pledged or frozen to avoid complications [1][7]. - The company will publish the redemption results and the delisting announcement for the bonds following the completion of the redemption process [7][8].